Erin S. Enright - Jan 14, 2022 Form 3 Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Role
Director
Signature
/s/ Erin S. Enright
Stock symbol
ERNA
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
3
Date filed
1/19/2022, 08:45 PM
Previous filing
Jan 5, 2022
Next filing
Apr 5, 2022

No securities are beneficially owned.

Remarks:

See Exhibit 24.1 - Power of Attorney